Dermatophytic Onychomycosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Dermatophytic Onychomycosis Treatment Trends and Forecast

The future of the global dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets. The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

A more than 150-page report is developed to help in your business decisions.

Dermatophytic Onychomycosis Treatment by Segment

The study includes a forecast for the global dermatophytic onychomycosis treatment by product type, route of administration, type, distribution channel, and region.

Dermatophytic Onychomycosis Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Tablets
• Nail Paints

Dermatophytic Onychomycosis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Topical

Dermatophytic Onychomycosis Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Prescribed
• Over-The-Counter

Dermatophytic Onychomycosis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Retail Pharmacies
• Online Channels

Dermatophytic Onychomycosis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Dermatophytic Onychomycosis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dermatophytic onychomycosis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dermatophytic onychomycosis treatment companies profiled in this report include-

• Bausch Health Companies
• Pfizer
• Galderma
• GlaxoSmithKline
• Janssen Pharmaceuticals
• Cipla
• Kaken Pharmaceuticals

Dermatophytic Onychomycosis Treatment Market Insights

Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Within this market, over-the-counter will remain the larger segment due to rapidly increasing ciclopirox sales.

North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Features of the Global Dermatophytic Onychomycosis Treatment Market

Market Size Estimates: Dermatophytic onychomycosis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dermatophytic onychomycosis treatment market size by various segments, such as by product type, route of administration, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Dermatophytic onychomycosis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, route of administration, type, distribution channel, and regions for the dermatophytic onychomycosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dermatophytic onychomycosis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the dermatophytic onychomycosis treatment market size?

Answer: The global dermatophytic onychomycosis treatment market is expected to reach an estimated $4.5 billion by 2030.

Q2. What is the growth forecast for dermatophytic onychomycosis treatment market?

Answer: The global dermatophytic onychomycosis treatment market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the dermatophytic onychomycosis treatment market?

Answer: The major drivers for this market are increased incidence of nail fungal infections is caused by the rising frequency of diabetes, growing number of elderly people, and growing research, the quick uptake of nail polish, and the surge in the introduction of new generic medication.

Q4. What are the major segments for dermatophytic onychomycosis treatment market?

Answer: The future of the dermatophytic onychomycosis treatment market looks promising with opportunities in the prescribed and over-the-counter markets.

Q5. Who are the key dermatophytic onychomycosis treatment market companies?

Answer: Some of the key dermatophytic onychomycosis treatment companies are as follows.

• Bausch Health Companies
• Pfizer
• Galderma
• GlaxoSmithKline
• Janssen Pharmaceuticals
• Cipla
• Kaken Pharmaceuticals

Q6. Which dermatophytic onychomycosis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that nail paints will remain the larger segment over the forecast period due to increasing adoption of jublia.

Q7. In dermatophytic onychomycosis treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising count of prescriptions for onychomycosis treatment.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the dermatophytic onychomycosis treatment market by product type (tablets and nail paints), route of administration (oral and topical), type (prescribed and over-the-counter), distribution channel (hospital pharmacies, retail pharmacies, and online channels), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?